These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. GPCR signalling from within the cell. Jong YI; Harmon SK; O'Malley KL Br J Pharmacol; 2018 Nov; 175(21):4026-4035. PubMed ID: 28872669 [TBL] [Abstract][Full Text] [Related]
4. The current state of GPCR-based drug discovery to treat metabolic disease. Sloop KW; Emmerson PJ; Statnick MA; Willard FS Br J Pharmacol; 2018 Nov; 175(21):4060-4071. PubMed ID: 29394497 [TBL] [Abstract][Full Text] [Related]
5. GPCRs in context: sexual dimorphism in the cardiovascular system. Mouat MA; Coleman JLJ; Smith NJ Br J Pharmacol; 2018 Nov; 175(21):4047-4059. PubMed ID: 29451687 [TBL] [Abstract][Full Text] [Related]
6. Identifying ligands at orphan GPCRs: current status using structure-based approaches. Ngo T; Kufareva I; Coleman JLj; Graham RM; Abagyan R; Smith NJ Br J Pharmacol; 2016 Oct; 173(20):2934-51. PubMed ID: 26837045 [TBL] [Abstract][Full Text] [Related]
7. Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function. Desai AJ; Miller LJ Br J Pharmacol; 2018 Nov; 175(21):4009-4025. PubMed ID: 28691227 [TBL] [Abstract][Full Text] [Related]
8. Highlights and hot topics in GPCR research from 'Down Under'. Smith NJ; May LT; Grimsey NL Br J Pharmacol; 2024 Jul; 181(14):2091-2094. PubMed ID: 38798136 [TBL] [Abstract][Full Text] [Related]
9. Emerging areas of opioid pharmacology. Kelly E; Henderson G; Bailey CP Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423 [TBL] [Abstract][Full Text] [Related]
10. When pharmacology meets the microbiome: new targets for therapeutics? Hyland NP; Cryan JF Br J Pharmacol; 2018 Dec; 175(24):4401-4403. PubMed ID: 30478976 [TBL] [Abstract][Full Text] [Related]
12. Superagonism at G protein-coupled receptors and beyond. Schrage R; De Min A; Hochheiser K; Kostenis E; Mohr K Br J Pharmacol; 2016 Oct; 173(20):3018-27. PubMed ID: 26276510 [TBL] [Abstract][Full Text] [Related]
13. Highlights into the pharmacology of nutraceuticals. Andrew R; Izzo AA Br J Pharmacol; 2020 Mar; 177(6):1209-1211. PubMed ID: 32133625 [TBL] [Abstract][Full Text] [Related]
15. Spotlight on small molecules in cardiovascular diseases. Wang X; Huang Y; Ji Y Br J Pharmacol; 2018 Apr; 175(8):1111-1113. PubMed ID: 29574891 [TBL] [Abstract][Full Text] [Related]
16. Editorial for GPR84 pharmacology. Milligan G Br J Pharmacol; 2024 May; 181(10):1497-1499. PubMed ID: 38456201 [TBL] [Abstract][Full Text] [Related]
17. Inventing new therapies without reinventing the wheel: the power of drug repurposing. Papapetropoulos A; Szabo C Br J Pharmacol; 2018 Jan; 175(2):165-167. PubMed ID: 29313889 [TBL] [Abstract][Full Text] [Related]
18. New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism. Vecchio EA; Baltos JA; Nguyen ATN; Christopoulos A; White PJ; May LT Br J Pharmacol; 2018 Nov; 175(21):4036-4046. PubMed ID: 29679502 [TBL] [Abstract][Full Text] [Related]
19. Pharmacology of cognition: a panacea for neuropsychiatric disease? Bailey SJ; Neill JC; Moran PM Br J Pharmacol; 2017 Oct; 174(19):3133-3135. PubMed ID: 28901012 [TBL] [Abstract][Full Text] [Related]
20. The importance of sex differences in pharmacology research. Gogos A; Langmead C; Sullivan JC; Lawrence AJ Br J Pharmacol; 2019 Nov; 176(21):4087-4089. PubMed ID: 31769019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]